Mirabegron and Metoprolol: What the Interaction Study Used

You take metoprolol, and a new bladder prescription says mirabegron. Before the first dose, ask the pharmacist to review that pair by name. The US mirabegron label identifies an interaction with metoprolol and says monitoring and possible dose adjustment may be needed for medicines processed by CYP2D6.¹

What the study measured

Walter Krauwinkel and colleagues studied drug concentrations in healthy volunteers. The metoprolol experiment included 12 men described as CYP2D6 extensive metabolizers, meaning the study selected a particular drug-metabolism group. It was an open-label, one-sequence crossover study, rather than a trial of long-term heart outcomes in women taking bladder treatment.²

With mirabegron 160 mg daily, metoprolol’s peak blood concentration was 1.90 times its comparison value. Total exposure, measured as the area under the concentration-time curve, was 3.29 times the comparison value. These are concentration measurements, not estimates that a patient is three times as likely to faint or develop a heart problem.²

The publisher’s abstract reports that the treatments were well tolerated. Twelve healthy men cannot establish the frequency of uncommon harms across older adults with heart disease and multiple prescriptions.²

Why the dose and formulation matter

The US label supplies an additional detail: participants took 160 mg immediate-release mirabegron daily for five days, with a single 100 mg metoprolol dose studied before and alongside mirabegron.¹

For adult overactive bladder, that same label starts extended-release mirabegron at 25 mg daily, with a possible increase to 50 mg after four to eight weeks. The interaction experiment therefore does not provide a personal exposure multiplier for either usual dose. It also does not supply a formula for changing your metoprolol prescription.¹

For the broader medicine choices, see our mirabegron and vibegron prescribing questions.

Symptoms still need attention

NHS³ guidance lists tiredness, dizziness and weakness among metoprolol’s possible side effects. If dizzy or weak, sit or lie down until it passes; do not drive or use machinery while affected. Tell a pharmacist or doctor about symptoms that persist or bother you. Those symptoms alone cannot establish that this particular interaction caused them.³

New chest pain, pain worse than your usual angina, or chest pain lasting more than a few minutes needs emergency assessment. NHS³ guidance names 999; in the US call 911, or use your country’s emergency number.³

The play

Try this: request a plan for this exact pair

1. Bring both medicine packets, the prescribed doses and the planned start date. Ask: “Does adding mirabegron change the monitoring or dose plan for my metoprolol?”
2. Ask which symptoms or pulse and blood-pressure readings should prompt a call, and when the first review should happen. Have the clinician write the thresholds for you.
3. Confirm the instructions before changing either prescription. Keep the plan beside the medicine list so another prescriber can see it.

Bring the medicine list with your bladder record

Laugh, Sneeze, Jump, Chapter 9, asks you to bring every medicine, including nonprescription products, alongside your three-day bladder record and to agree on a treatment check-in. That preparation fits this conversation; the book does not provide a metoprolol adjustment schedule. See the book.